Bioventix Statistics

Total Valuation

Bioventix has a market cap or net worth of GBP 148.91 million. The enterprise value is 143.77 million.

Market Cap	148.91M
Enterprise Value	143.77M

Important Dates

The next estimated earnings date is Friday, June 27, 2025.

Earnings Date	Jun 27, 2025
Ex-Dividend Date	Apr 10, 2025

Share Statistics

Bioventix has 5.22 million shares outstanding. The number of shares has decreased by -0.20% in one year.

Current Share Class	5.22M
Shares Outstanding	5.22M
Shares Change (YoY)	-0.20%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	6.01%
Owned by Institutions (%)	70.25%
Float	4.15M

Valuation Ratios

The trailing PE ratio is 19.24.

PE Ratio	19.24
Forward PE	n/a
PS Ratio	10.90
PB Ratio	13.20
P/TBV Ratio	13.20
P/FCF Ratio	19.83
P/OCF Ratio	19.75
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 13.57, with an EV/FCF ratio of 19.14.

EV / Earnings	18.32
EV / Sales	10.52
EV / EBITDA	13.57
EV / EBIT	13.72
EV / FCF	19.14

Financial Position

The company has a current ratio of 7.01

Current Ratio	7.01
Quick Ratio	6.69
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 69.08% and return on invested capital (ROIC) is 57.69%.

Return on Equity (ROE)	69.08%
Return on Assets (ROA)	50.09%
Return on Invested Capital (ROIC)	57.69%
Return on Capital Employed (ROCE)	92.94%
Revenue Per Employee	803,738
Profits Per Employee	461,500
Employee Count	17
Asset Turnover	1.04
Inventory Turnover	2.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.77% in the last 52 weeks. The beta is 0.47, so Bioventix's price volatility has been lower than the market average.

Beta (5Y)	0.47
52-Week Price Change	-33.77%
50-Day Moving Average	2,648.95
200-Day Moving Average	3,408.31
Relative Strength Index (RSI)	67.39
Average Volume (20 Days)	9,817

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Bioventix had revenue of GBP 13.66 million and earned 7.85 million in profits. Earnings per share was 1.48.

Revenue	13.66M
Gross Profit	12.43M
Operating Income	10.48M
Pretax Income	10.41M
Net Income	7.85M
EBITDA	10.59M
EBIT	10.48M
Earnings Per Share (EPS)	1.48

Full Income Statement

Balance Sheet

The company has 5.14 million in cash and n/a in debt, giving a net cash position of 5.14 million or 0.98 per share.

Cash & Cash Equivalents	5.14M
Total Debt	n/a
Net Cash	5.14M
Net Cash Per Share	0.98
Equity (Book Value)	11.28M
Book Value Per Share	2.16
Working Capital	10.41M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.54 million and capital expenditures -29,774, giving a free cash flow of 7.51 million.

Operating Cash Flow	7.54M
Capital Expenditures	-29,774
Free Cash Flow	7.51M
FCF Per Share	1.44

Full Cash Flow Statement

Margins

Gross margin is 90.95%, with operating and profit margins of 76.72% and 57.42%.

Gross Margin	90.95%
Operating Margin	76.72%
Pretax Margin	76.20%
Profit Margin	57.42%
EBITDA Margin	77.52%
EBIT Margin	76.72%
FCF Margin	54.97%

Dividends & Yields

This stock pays an annual dividend of 1.55, which amounts to a dividend yield of 5.44%.

Dividend Per Share	1.55
Dividend Yield	5.44%
Dividend Growth (YoY)	-0.63%
Years of Dividend Growth	1
Payout Ratio	103.12%
Buyback Yield	0.20%
Shareholder Yield	5.64%
Earnings Yield	5.27%
FCF Yield	5.04%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Bioventix has an Altman Z-Score of 81.78.

Altman Z-Score	81.78
Piotroski F-Score	n/a